Skip to main content

FDA approves J&J's device for heart condition

By Reuters  
   November 08, 2024

The FDA has approved Johnson & Johnson's new tab device for a type of condition which causes abnormal heart rhythm, the company said on Thursday. The device, Varipulse, is a pulsed field ablation system. Medical device makers such as Boston Scientific and Medtronic also have devices approved for atrial fibrillation, a condition that is characterized by an irregular rhythm of the heart.

Full story


Get the latest on healthcare leadership in your inbox.